Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamer E Fandy

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 1, 2004
Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayersKwang-Jin Kim, Tamer E Fandy, Vincent H L Lee, et al.
Molecular Cancer Therapeutics|March 1, 2006
IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cellsNaoko Takebe, Xiangfei Cheng, Tamer E Fandy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 24, 2022
Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating AgentsSridhar A Malkaram, Aymen Shatnawi, Jun Fan, et al.
Epigenetics|September 3, 2016
The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effectHazem E Hassan, Jean-Arnaud Keita, Lawrence Narayan, et al.
Chemmedchem|September 29, 2016
15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of LeukemiaDilini C Gunasekara, Mary M Zheng, Tara Mojtahed, et al.
Bioorganic Chemistry|June 21, 2025
Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancerSamar M Mogheith, Heba Abdelrasheed Allam, Manal Abdel Fattah Ezzat, et al.
Cells|January 28, 2026
Microbial Modulation: Unraveling the Influence of Gut Microbiota on Macrophage Polarization in Tumor MicroenvironmentsJonathan Trejo, Hayes Koegeboehn, Farah Faizuddin, et al.
Scientific Reports|June 27, 2020
Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemiaHetty E Carraway, Sridhar A Malkaram, Yana Cen, et al.
Scientific Reports|September 24, 2020
Author Correction: Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemiaHetty E Carraway, Sridhar A Malkaram, Yana Cen, et al.
Journal of Medicinal Chemistry|December 14, 2020
HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic StabilityTamer A Elwaie, Safinaz E Abbas, Enayat I Aly, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 1, 2004
Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayersKwang-Jin Kim, Tamer E Fandy, Vincent H L Lee, et al.
Molecular Cancer Therapeutics|March 1, 2006
IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cellsNaoko Takebe, Xiangfei Cheng, Tamer E Fandy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 24, 2022
Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating AgentsSridhar A Malkaram, Aymen Shatnawi, Jun Fan, et al.
Epigenetics|September 3, 2016
The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effectHazem E Hassan, Jean-Arnaud Keita, Lawrence Narayan, et al.
Chemmedchem|September 29, 2016
15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of LeukemiaDilini C Gunasekara, Mary M Zheng, Tara Mojtahed, et al.
Bioorganic Chemistry|June 21, 2025
Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancerSamar M Mogheith, Heba Abdelrasheed Allam, Manal Abdel Fattah Ezzat, et al.
Cells|January 28, 2026
Microbial Modulation: Unraveling the Influence of Gut Microbiota on Macrophage Polarization in Tumor MicroenvironmentsJonathan Trejo, Hayes Koegeboehn, Farah Faizuddin, et al.
Scientific Reports|June 27, 2020
Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemiaHetty E Carraway, Sridhar A Malkaram, Yana Cen, et al.
Scientific Reports|September 24, 2020
Author Correction: Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemiaHetty E Carraway, Sridhar A Malkaram, Yana Cen, et al.
Journal of Medicinal Chemistry|December 14, 2020
HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic StabilityTamer A Elwaie, Safinaz E Abbas, Enayat I Aly, et al.
Pageof 4